Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:biotechnology
|
| gptkbp:acquired_by |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:collaborations |
various research institutions
|
| gptkbp:dissolved |
gptkb:2007
|
| gptkbp:focus |
gptkb:pharmaceuticals
|
| gptkbp:founded |
gptkb:1999
|
| gptkbp:founder |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:headquarters |
gptkb:San_Diego,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lilly ICOS
|
| gptkbp:industry |
healthcare
|
| gptkbp:key_people |
gptkb:John_C._Lechleiter
|
| gptkbp:notable_products |
gptkb:Cialis
|
| gptkbp:partnership |
gptkb:ICOS_Corporation
|
| gptkbp:products |
gptkb:Tadalafil
|
| gptkbp:research_areas |
erectile dysfunction
|
| gptkbp:services |
drug development
|
| gptkbp:type |
gptkb:Partnerships
|
| gptkbp:website |
www.lilly.com
|
| gptkbp:bfsParent |
gptkb:Eli_Lilly_and_Company
gptkb:LLY |
| gptkbp:bfsLayer |
5
|